Treatment of Restrictive Cardiomyopathy After Survived Cardiac Arrest or Haemodynamically Unstable Ventricular Arrhythmia

This protocol addresses a high-risk subset of patients with restrictive cardiomyopathy (RCM) who have experienced a life-threatening cardiac event — either a survived cardiac arrest or a ventricular arrhythmia that caused haemodynamic instability.

Clinical Scenario

Patient presents with restrictive cardiomyopathy who has survived a cardiac arrest, or who has recovered from a ventricular arrhythmia that caused haemodynamic instability. This specific history substantially elevates the risk of sudden cardiac death and guides the management strategy.

Treatment Approach

Management in this setting centres on an implantable device-based intervention aimed at reducing the risk of sudden death — the full criteria, clinical decision pathway, and procedural considerations are available in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/eurheartj/ehad194

ICD implantation is recommended to reduce the risk of sudden death and all-cause mortality in patients with RCM who have survived a cardiac arrest or have recovered from a ventricular arrhythmia causing haemodynamic instability.

View source ↗